Stay updated on Rituximab/Pembrolizumab +/- Lenalidomide in Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Rituximab/Pembrolizumab +/- Lenalidomide in Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Rituximab/Pembrolizumab +/- Lenalidomide in Lymphoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page revision label was updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-23T15:01:05.000Z thumbnail image
  3. Check
    24 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Added the MeSH term Malignant lymphoma, large B-cell, diffuse. Introduced a Resources section with a link to the Genetic and Rare Diseases Information Center.
    Difference
    0.1%
    Check dated 2026-04-02T00:43:31.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Added revision v3.5.0 and removed revision v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-18T18:10:05.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Added new revision entry v3.4.3 with March 2026 dates; removed prior revision entry v3.4.2 and February 2026 dates.
    Difference
    0.3%
    Check dated 2026-03-11T14:41:12.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Added Results Posted with primary and secondary outcomes (ORR, CRR, PFS, OS) and related dates, including Results First Submitted/Posted timestamps. Also attached the Study Protocol and Statistical Analysis Plan PDF.
    Difference
    1%
    Check dated 2026-03-04T11:38:48.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Added: Results Submitted and Revision: v3.4.2; Removed: No Results Posted and Revision: v3.4.1. The page now shows that results have been submitted and reflects the latest site revision.
    Difference
    0.4%
    Check dated 2026-02-11T02:17:06.000Z thumbnail image

Stay in the know with updates to Rituximab/Pembrolizumab +/- Lenalidomide in Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Rituximab/Pembrolizumab +/- Lenalidomide in Lymphoma Clinical Trial page.